This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Philip Morris (PM) Gains on RRPs Popularity & Pricing Power
by Zacks Equity Research
Philip Morris' (PM) IQOS devices are gaining traction among consumers. Moreover, pricing power, especially for combustible products, is an upside.
Altria (MO) Benefits From Low-Risk Products & Pricing Power
by Zacks Equity Research
Altria (MO) gains from expansion of IQOS and oral tobacco offerings such as on! Moreover, pricing power is aiding revenues.
Altria (MO) Poised on Solid Pricing, Growth in Low Risk Products
by Zacks Equity Research
Altria (MO) gains from rising popularity of IQOS and oral tobacco offerings. Moreover, pricing power is supporting revenue growth.
Phillip Morris (PM) Poised for Growth on RRPs & Strong Pricing
by Zacks Equity Research
Philip Morris' (PM) strong offerings in the reduced risk products space and solid pricing of combustible products are driving growth.
Turning Point Brands (TPB) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Turning Point Brands (TPB) delivered earnings and revenue surprises of 18.31% and 1.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Philip Morris, Altria Group and Turning Point Brands
by Zacks Equity Research
Zacks Industry Outlook Highlights: Philip Morris, Altria Group and Turning Point Brands
RRPs, Pricing Light Up Tobacco Space Prospects: 3 Stock to Watch
by Vidya Nair
Rising popularity of low risk products, along with solid pricing is a boon for a number of tobacco industry players such as PM, MO and TPB. However, low cigarette sales volumes are a concern for several players.
Altria (MO) Gains on Low Risk Tobacco Products & Strong Pricing
by Zacks Equity Research
Altria's (MO) efforts to boost oral tobacco offerings and expansion of IQOS across stores are yielding. Moreover, pricing power is aiding revenue growth.
Will RRPs Growth Keep Driving Philip Morris (PM) in 2021?
by Zacks Equity Research
Philip Morris (PM) is gaining from growing popularity of IQOS, which is boosting revenues in the RRPs category.
Has Turning Point Brands (TPB) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (TPB) Outperforming Other Consumer Staples Stocks This Year?
Altria (MO) Gains on Low-Risk Products Amid Soft Cigarette Sales
by Zacks Equity Research
Altria (MO) is gaining from the popularity of low-risk tobacco alternatives such as IQOS and on!, as well as prudent pricing strategies.
RRPs Gaining Popularity: 3 Tobacco Stocks to Watch in 2021
by Vidya Nair
Tobacco industry players like PM, MO, and TPB are poised to benefit from rising popularity of low-risk tobacco alternatives. However, low cigarette sales volumes are likely to remain a headwind.
Philip Morris's (PM) IQOS 3 Receives FDA Authorization for Sale
by Zacks Equity Research
FDA approves the sale of Philip Morris's (PM) IQOS devices in the United States. The latest device includes a number of technological advancements compared with its predecessors.
Has Turning Point Brands (TPB) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (TPB) Outperforming Other Consumer Staples Stocks This Year?
Zacks.com featured highlights include: Turning Point Brands, Herc Holdings, Carriage Services, Systemax and CBIZ
by Zacks Equity Research
Zacks.com featured highlights include: Turning Point Brands, Herc Holdings, Carriage Services, Systemax and CBIZ
Check These 6 Top-Rated Stocks With Solid Net Profit Margins
by Anirudha Bhagat
Let's take a look at the six top-ranked stocks with impressive net profit margins for an enriching portfolio.
Turning Point Brands (TPB) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Turning Point Brands (TPB).
Has Turning Point Brands (TPB) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (TPB) Outperforming Other Consumer Staples Stocks This Year?
Altria's (MO) Q3 Earnings Surpass Estimates on Solid Pricing
by Zacks Equity Research
Altria's (MO) third-quarter 2020 results reflect strong pricing in smokeable and oral tobacco product segments. Management lifts the lower end of its previously guided earnings view.
Turning Point Brands (TPB) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Turning Point Brands (TPB) delivered earnings and revenue surprises of 29.31% and 12.74%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Turning Point Brands (TPB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Turning Point Brands (TPB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oral Tobacco Unit Supports Altria Amid Poor Cigarette Sales
by Zacks Equity Research
Altria (MO) is gaining from rising popularity of low risk tobacco alternatives. However the company's smokeable unit is bearing the brunt of soft cigarette sales.
RRPs a Respite for Philip Morris Amid Low Cigarette Sales
by Zacks Equity Research
Philip Morris (PM) is gaining from growing popularity of IQOS. However, low cigarette sales is a dampener.
4 Tobacco Stocks to Watch Amid Rising Popularity of RRPs
by Zacks Equity Research
Zacks Tobacco industry players like PM, MO, VGR and TPB are poised to benefit from rising popularity of low risk tobacco alternatives such as e-cigarettes and vaping products. However, low cigarette sales volumes are likely to remain a worry.
4 Tobacco Stocks to Watch Amid Rising Popularity of RRPs
by Zacks Equity Research
Zacks Tobacco industry players like PM, MO, VGR and TPB are poised to benefit from rising popularity of low risk tobacco alternatives such as e-cigarettes and vaping products. However, low cigarette sales volumes are likely to remain a worry.